Q4 Briefing 2020
Filed with ASX · · 25 pages · English
On 6ix: 6ix.com/news/q4-briefing-2020
PhD(Med), MPhil(Med), FASE, DMU(Cardiol) Chairman, CEO, Chief Scientist, Uscom Limited, Sydney, Australia Critical Care Research Group, School of Medicine, The University of Queensland, Brisbane, Australia “Uscom has a dedicated focus on the development and marketing of innovative noninvasive cardiovascular and pulmonary medical devices Current record revenue growth is from the USCOM 1A, and we ha
In the deck
Earlier from Uscom
- Uscom Partners with AD for BP Plus New Advanced Modules
- Uscom Partners with UTAS in IDEAL eHealth Initiative
- Q3 Investor Presentation COVID-19
- Uscom Investor Update - Coronavirus
- USCOM 1A in New International Sepsis Guidelines for Children
Later from Uscom
- Quarterly Activities Report - June 2020
- FY2020 Q4 Investor Briefing
- USCOM 1A Evidence for Early Treatment of Preeclampsia
- Pause in Trading
- Uscom VENTITEST Global Release
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom